Amicus Therapeutics

Amicus Therapeutics is now part of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. For more information on BioMarin, please visit https://www.biomarin.com/ and follow @BioMarin Pharmaceutical Inc. on LinkedIn for updates.

Est. revenue: $500M–$1B
Total raised: $2.6B
Latest round: Post-IPO Debt
Employees: 519

Claim profile

Funding & revenue at Amicus Therapeutics

How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.

Estimated annual revenue

$500M–$1B

Modeled range, not company-reported

Total capital raised

$2.6B

19 known investors

Latest round

Post-IPO Debt · $30M

Oct 2023

Publicly traded

FOLD, AMICUSTHERAPEUTICS

IPO May 2007

Status

Acquired

Investors

BioPharma CreditBlackstone Credit & InsuranceBlackstone Life SciencesCHL Medical PartnersCanaan PartnersFirst Citizens Innovation BankingFrazier Healthcare PartnersGarden State Life Sciences VentureGlaxoSmithKlineHayfin Capital ManagementMichael J. Fox FoundationMidCap FinancialMuscular Dystrophy AssociationNew Enterprise AssociatesOxford Finance LLCPalo Alto InvestorsProspect Venture PartnersQuaker BioVenturesRadius Ventures

Growth signals

How fast Amicus Therapeutics is adding people, roles, and audience.

Employees

519

Reported band 501-1000

LinkedIn followers

58K

+23.2% year over year

Headcount change

MoM: -3.2%; -17 people
QoQ: -9.6%; -55 people
6mo: -16.7%; -104 people
YoY: -16.2%; -100 people
2yr: -13.2%; -79 people

Team composition

Where Amicus Therapeutics concentrates its people — a read on which function a fractional leader would plug into.

By function

Operations6112%
Sales5010%
Healthcare Services499%
Business Development489%
Research459%
Quality Assurance377%
Legal357%
Accounting275%

By region

United States270
New Jersey, United States131
New York City Metropolitan Area129
United Kingdom88
England, United Kingdom77
Greater Philadelphia47

Inside Amicus Therapeutics

What the business focuses on, where it operates, and how employees rate it.

Markets

NASDAQ

Offices

3675 Market Street, Philadelphia , PA, 19104, US
Amicus Therapeutics UK, Marlow, SL7 1HZ , GB
Amicus Therapeutics Germany, Munchen, Germany, 81829, DE
Amicus Therapeutics Spain, Calle Orense no 4, 2a planta, Madrid, 28020, ES
Amicus Therapeutics Italy, Via Giovanni Boccaccio, 11 5° Floor, Milano, 20123, IT
Amicus Therapeutics Netherlands, Science Park 402, Amsterdam, 1098XH, NL
Amicus Therapeutics France, 12 Place de La Défense, Paris La Défense Cedex, France, 92974 , FR
Amicus Therapeutics Japan, Otemachi, Chiyodaku, Tokyo, 1000004, JP

Competitors

Companies in the same market as Amicus Therapeutics.

http://www.escapebio.com/https://www.pharmather.com/http://www.ampiopharma.comhttps://www.amatechlabs.com/http://www.orphazyme.com/http://www.amylon.comhttps://amazinum.com/https://photys.comhttp://www.amnesty.orghttps://lystherapeutics.com/http://www.cff.orghttps://www.travere.comhttp://www.acertx.comhttp://www.phiopharma.comhttp://www.am-pharma.comhttp://allyxthera.com